GeneDx Holdings Corp. (WGS) Net margin 2019–2025
GeneDx Holdings Corp. (WGS) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.9%FY2025 · since FY2019: -15.1% → -4.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.9% | +12.2 pp |
| FY2024 | -17.1% | +69.7 pp |
| FY2023 | -86.8% | +147.1 pp |
| FY2022 | -233.9% | -118.3 pp |
| FY2021 | -115.6% | +18.9 pp |
| FY2020 | -134.6% | -119.4 pp |
| FY2019 | -15.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice